BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36809781)

  • 1. Physioxia improves the selectivity of hematopoietic stem cell expansion cultures.
    Igarashi KJ; Kucinski I; Chan YY; Tan TK; Khoo HM; Kealy D; Bhadury J; Hsu I; Ho PY; Niizuma K; Hickey JW; Nolan GP; Bridge KS; Czechowicz A; Gottgens B; Nakauchi H; Wilkinson AC
    Blood Adv; 2023 Jul; 7(14):3366-3377. PubMed ID: 36809781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
    Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
    Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease.
    Tijaro-Ovalle NM; Karantanos T; Wang HT; Boussiotis VA
    Front Immunol; 2019; 10():295. PubMed ID: 30891031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation.
    Wilkinson AC; Ishida R; Kikuchi M; Sudo K; Morita M; Crisostomo RV; Yamamoto R; Loh KM; Nakamura Y; Watanabe M; Nakauchi H; Yamazaki S
    Nature; 2019 Jul; 571(7763):117-121. PubMed ID: 31142833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy prevents graft failure during murine graft-versus-host disease.
    Lineburg KE; Leveque-El Mouttie L; Hunter CR; Le Texier L; McGirr C; Teal B; Blazar BR; Lane SW; Hill GR; Lévesque JP; MacDonald KPA
    Blood Adv; 2024 Apr; 8(8):2032-2043. PubMed ID: 38295282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of low-cost ex vivo hematopoietic stem cell expansion].
    Kimura T; Yamazaki S
    Rinsho Ketsueki; 2022; 63(10):1422-1429. PubMed ID: 36351651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-genotoxic Restoration of the Hematolymphoid System in Fanconi Anemia.
    Chan YY; Ho PY; Swartzrock L; Rayburn M; Nofal R; Thongthip S; Weinberg KI; Czechowicz A
    Transplant Cell Ther; 2023 Mar; 29(3):164.e1-164.e9. PubMed ID: 35995393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex Vivo Expansion and Genetic Manipulation of Mouse Hematopoietic Stem Cells in Polyvinyl Alcohol-Based Cultures.
    Khoo HM; Meaker GA; Wilkinson AC
    J Vis Exp; 2023 Feb; (192):. PubMed ID: 36847389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M; Dhedin N; Michallet AS
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvinyl alcohol hydrolysis rate and molecular weight influence human and murine HSC activity ex vivo.
    Sudo K; Yamazaki S; Wilkinson AC; Nakauchi H; Nakamura Y
    Stem Cell Res; 2021 Oct; 56():102531. PubMed ID: 34509158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-targeted Delta-like 1 promotes hematopoietic stem cell expansion ex vivo and engraftment in hematopoietic tissues in vivo.
    Tian DM; Liang L; Zhao XC; Zheng MH; Cao XL; Qin HY; Wang CM; Liang YM; Han H
    Stem Cell Res; 2013 Sep; 11(2):693-706. PubMed ID: 23727445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.
    Müller AM; Linderman JA; Florek M; Miklos D; Shizuru JA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14721-6. PubMed ID: 20679222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence.
    Luo Y; Li L; Zou P; Wang J; Shao L; Zhou D; Liu L
    Transplantation; 2014 Jan; 97(1):20-9. PubMed ID: 24092377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of endothelial progenitor cells accelerates hematopoietic and immune reconstitution, and ameliorates the graft-versus-host disease after hematopoietic stem cell transplantation.
    Zeng L; Chen C; Song G; Yan Z; Xu S; Jia L; Ding S; Cao J; Chen W; Cheng H; Li Z; Sang W; Wang L; Li Y; Xu K
    Cell Biochem Biophys; 2012 Dec; 64(3):213-22. PubMed ID: 22806343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.